The Impact of Nanotechnology in Drug Delivery Systems: A Comprehensive Study

Abstract:

The development and manufacturing of materials at the atomic and molecular scale is known as nanotechnology. According to the National Nanotechnology Initiative, structures roughly in the 1−100 nm size range in at least one dimension are referred to be nanotechnology. Despite this limit on size, structures as small as a few hundred nanometres are frequently referred to as nanotechnology. These structures are created through top-down or bottom-up engineering of individual components. In this work, we primarily address the use of nanotechnology in medication delivery and identify a number of promising areas where existing and developing nanotechnologies may open up completely new therapeutic avenues. Nanotechnology is the exploitation of the unique properties of materials at the nanoscale. Nanotechnology has gained popularity in several industries, as it offers better built and smarter products. The application of nanotechnology in medicine and healthcare is referred to as nanomedicine, and it has been used to combat some of the most common diseases, including cardiovascular diseases and cancer. In recent decade drug development and delivery become one of the high growing, demanding and manufacturing sector with high capital investment. Despite their numerous advantages, the potential toxicity of nanoparticles used in drug delivery systems remains a significant concern. This review explores the challenges associated with conventional drug formulations, highlights the benefits of nanoparticles in drug delivery, and discusses their possible toxic effects. Keywords: Drug target, Nanomaterials, Liposome, Nanotechnology, Nanomedicine, Drug delivery system.

View PDF